Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Where We Are Indexed
Past Issue Archives
Clinical Communication
CME
Outcomes
Research
In Review
Editorial Board
Information for Authors
Author Form

Reprints, Permissions, & Copyright
Site Map
 
JCOM
BACK ISSUE articles are $15 each.
 
International credit cards NOT accepted.



JCOM Paid Subscribers
LOG IN
user name:
password:
 
Forgot password?

JCOM Abstract


J Clin Outcomes Manage 
2013 Feb;20(2):60-68
Effectiveness of inhaled combined corticosteroid/long acting bronchodilator treatment in reducing COPD exacerbations and short-acting bronchodilator use
Mapel D, Roberts MH, Blanchette CM, Petersen H, Ramachandran S

ABSTRACT Objective: To compare budesonide/formoterol (BFC) and fluticasone propionate/salmeterol (FSC) in their ability to reduce COPD exacerbations using a novel risk stratification approach. Design: Retrospective cohort study with propensity matching and stratification by short-acting beta2-agonist (SABA) use. Participants: 7704 COPD patients identified using 2 U.S. health claims databases (study period: 1/1/2004 to 4/30/2009). Measurements: Users of BFC and FSC were stratified by SABA fills in the 6 months prior to the start of therapy (index date). Exacerbation events before and after the index date were compared, and proportional hazard models used to examine exacerbation risk by baseline SABA use. Results: At baseline, 6% (6.2%, BFC; 5.8%, FSC) had a COPD-related hospitalization or emergency department (ED) visit. Post-index, this was reduced to 4.8% (P < 0.001) among all patients (4.9%, BFC, 4.7%, FSC). Change was greatest among high SABA users (9% pre-index to 4.9% post-index, P < 0.001). SABA use post-index was reduced in both groups, with slightly lower need for SABA refills seen among BFC users. SABA use was correlated with increased exacerbations during the baseline period and was predictive of exacerbations during the follow-up period. Conclusions: BFC and FSC had equivalent effectiveness in reduction in ED visits and hospitalizations for COPD exacerbations, but BFC users had lower subsequent need for SABA fills. Increased SABA use is a predictor of COPD exacerbation among COPD patients in the general population.

Original Research

Search the Turner White index to find abstracts of articles published in JCOM.





New issues are posted one month following publication of the printed journal.



View past issue archives:    2013    2012    2011    2010    2009    2008    2007
   2006    2005    2004    2003     2002     2001     2000     1999



Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2014, Turner White Communications
Updated 1/20/14 • jdw